Key Updates
VEA has advanced +2.63% since the December 5th report to $63.91, establishing another all-time high and extending YTD gains to +2.30% in early 2026. The fund's momentum continues to be supported by Vanguard's institutional endorsement, which identified non-US developed market equities as one of the two most attractive stock investments for the next 5-10 years with projected 6% annual returns. The investment thesis remains intact as VEA continues to outperform expectations, though the YTD figure reflects the calendar year reset from 2025's exceptional +30.21% performance.
Current Trend
VEA is trading at $63.91, representing a new all-time high and demonstrating sustained upward momentum across all timeframes: +1.12% (1-day), +1.74% (5-day), +3.01% (1-month), and +11.68% (6-month). The YTD performance of +2.30% reflects the strong start to 2026 following the calendar reset. The fund has now advanced +2.63% since the previous report, building upon the recovery pattern established in late November. The consistent positive performance across multiple time horizons indicates robust institutional demand and confirms the breakout above the previous resistance level of $62.27 established in early December.
Investment Thesis
The core investment thesis centers on VEA's exposure to attractively valued non-US developed market equities during a period of relative undervaluation compared to US growth stocks. Vanguard's 2026 outlook provides institutional validation, projecting 6% annual returns for non-US developed markets over the next 5-10 years, positioning these equities as one of only two recommended stock investments alongside US value stocks (7% projected returns). The thesis is predicated on superior valuation metrics relative to US technology stocks, which face rising risks despite incomplete AI adoption cycles. VEA's broad diversification across developed international markets provides exposure to value-oriented sectors including industrials, financials, and select consumer segments that may benefit from the rotation away from concentrated mega-cap technology positions.
Thesis Status
The investment thesis is performing ahead of expectations and gaining institutional momentum. Vanguard's explicit endorsement of non-US developed market equities as a top investment for the next decade directly validates the VEA positioning. The fund's 2025 performance of +30.3% significantly outpaced the S&P 500's +15% gain, demonstrating the material outperformance potential that underpins the thesis. The early 2026 momentum (+2.30% YTD) suggests continued institutional flows into this asset class. The thesis remains strengthened by the valuation gap between international developed markets and US growth stocks, particularly as risks rise in the technology sector due to emerging competitors and high infrastructure capital expenditures impacting earnings.
Key Drivers
The primary catalyst is Vanguard's institutional endorsement identifying non-US developed market stocks as one of two best investments for 5-10 years, with projected 6% annual returns. This recommendation from a $11.9 trillion asset manager provides significant validation and likely drives institutional allocation decisions. The second major driver is the valuation differential, as non-US developed markets offer more attractive valuations than US tech stocks, which have yet to fully price in AI adoption benefits despite rising sector risks. The rotation from concentrated US mega-cap technology positions toward international diversification continues to support flows, as investors seek exposure beyond the 32% concentration in Microsoft, Nvidia, and Apple that characterizes US growth funds. Market-wide factors include the completion of only 30%-40% of the AI investment cycle, suggesting extended timeframes before full valuation realization in US tech stocks.
Technical Analysis
VEA exhibits strong technical momentum with the current price of $63.91 representing a new all-time high, breaking above the December resistance at $62.27. The fund demonstrates consistent upward trajectory across all measured timeframes, with particularly robust 6-month performance (+11.68%) indicating sustained institutional accumulation. The +2.30% YTD gain in just five trading days of 2026 suggests continued momentum from 2025's exceptional performance. Support levels are well-established at $62.27 (previous high from December 5th) and $61.00 (November 26th level). The price action shows no signs of exhaustion, with steady gains rather than parabolic moves, indicating healthy accumulation rather than speculative excess. The technical picture remains constructive with higher highs and higher lows across multiple timeframes.
Bull Case
- Institutional Validation: Vanguard, managing $11.9 trillion in assets, identified non-US developed market equities as one of only two best stock investments for the next 5-10 years with projected 6% annual returns, providing significant institutional credibility and likely driving sustained allocation flows. Source
- Superior Valuation Positioning: Non-US developed markets offer more attractive valuations compared to US technology stocks, which have yet to fully price in AI adoption benefits and face rising risks from emerging competitors and high infrastructure capital expenditures. Source
- Demonstrated Outperformance: VEA rose 30.3% in 2025 compared to the S&P 500's 15% gain, demonstrating material outperformance potential and validating the rotation thesis toward international developed markets. Source
- Sector Diversification Benefits: Exposure to value-oriented sectors including industrials, financials, and select consumer segments provides diversification away from concentrated mega-cap technology positions that dominate US growth funds. Source
- Technical Momentum: Consistent positive performance across all timeframes (+11.68% over 6 months, +2.30% YTD) with new all-time highs indicates sustained institutional demand and healthy accumulation patterns without speculative excess. Source
Bear Case
- Extended AI Investment Cycle: The AI investment cycle is only 30%-40% complete, suggesting US technology stocks may continue to attract capital despite valuation concerns, potentially delaying or limiting rotation flows into international markets. Source
- Lower Return Projections vs. US Value: Vanguard projects 6% annual returns for non-US developed markets compared to 7% for US value stocks, indicating domestic value opportunities may be relatively more attractive for return-focused investors. Source
- Concentration Risk in US Growth Alternatives: While VEA avoids US mega-cap concentration, the reference to US growth funds showing 32% concentration in top three holdings and 62% in top 10 highlights that alternative high-performing strategies exist with proven track records. Source
- Recent Volatility in Growth Comparables: US growth funds experienced 33% drawdowns during the 2022 bear market, and while VEA offers diversification, international markets are not immune to global risk-off periods that could impact developed market equities. Source
- Momentum Exhaustion Risk: Following 30.3% gains in 2025 and continued advances in early 2026, near-term profit-taking or consolidation could occur as the fund trades at all-time highs with limited technical resistance to guide further upside targets. Source